1-9 of 9
Amit Kumar Mitra, PhD
Close
Sort by
Journal Articles

Repurposing Clofazimine As a Novel Drug for the Treatment of PI-Resistant Stem Cell-like Subclones in Myeloma

Harish Kumar, PhD, Ujjal Kumar Mukherjee, PhD, Suman Mazumder, PhD, Sabyasachi Sanyal, PhD, Brian G. Van Ness, PhD, Amit Kumar Mitra, PhD MSc, BSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 4418.
https://doi.org/10.1182/blood-2019-131596
Published: 2019
Journal Articles

In silico Prediction Followed By in Vitro validation Identifies the Survivin Inhibitor YM155 As a Potent Secondary Drug Against Pi-Resistant Myeloma

Harish Kumar, PhD, Ujjal Kumar Mukherjee, PhD, Li Chen, PhD, Amit Kumar Mitra, PhD MSc, BSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 5543.
https://doi.org/10.1182/blood-2019-131923
Published: 2019
Journal Articles

Secdrug: A Computational Method for Discovering Novel Secondary Drug Combinations Using Large-Scale Pharmacogenomics Databases

Li Chen, PhD, Ujjal Kumar Mukherjee, PhD, Emily Rankine, Brian G. Van Ness, PhD, Amit Kumar Mitra, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4473.
https://doi.org/10.1182/blood-2018-99-117653
Published: 2018
Journal Articles

Gene Expression Profiling of Kinetic Response to Proteasome Inhibitors in Innate and Acquired Resistant Multiple Myeloma

Amit Kumar Mitra, PhD, Vijay G. Ramakrishnan, PhD, Shaji K Kumar, MD, S. Vincent Rajkumar, MD, Brian G. Van Ness, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4405.
https://doi.org/10.1182/blood.V130.Suppl_1.4405.4405
Published: 2017
Journal Articles

Scattome: A Single-Cell Analysis of Targeted Transcriptome Program to Predict Drug Sensitivity of Single Cells within Human Myeloma Tumors

Amit Kumar Mitra, PhD, Ujjal Mukherjee, PhD, Taylor Harding, Holly Stessman, PhD, Ying Li, Jen Jin, Shaji K Kumar, MD, S. Vincent Rajkumar, Brian G Van Ness, PhD
Journal: Blood
Blood (2015) 126 (23): 4249.
https://doi.org/10.1182/blood.V126.23.4249.4249
Published: 2015
Journal Articles

Creation of a Gene Expression Signature-Based Prediction Model Specific to Proteasome Inhibitor Response in Multiple Myeloma

Amit Kumar Mitra, PhD, Ujjal Mukherjee, PhD, Taylor Harding, Snigdhansu Chatterjee, PhD, Brian G Van Ness, PhD
Journal: Blood
Blood (2015) 126 (23): 3053.
https://doi.org/10.1182/blood.V126.23.3053.3053
Published: 2015
Journal Articles

Single-Cell Transcriptomics Identifies Intra-Tumor Heterogeneity in Human Myeloma Cell Lines

Amit Kumar Mitra, PhD, Holly Stessman, PhD, Michael A. Linden, MDPhD, Brian Van Ness, PhD
Journal: Blood
Blood (2014) 124 (21): 3385.
https://doi.org/10.1182/blood.V124.21.3385.3385
Published: 2014
Journal Articles

Comparative Analysis of in Vitro Chemosensitivity to Four Proteasome Inhibitors in Human Myeloma Cell Lines

Amit Kumar Mitra, PhD, Taylor S Harding, B.A., Brian Van Ness, PhD
Journal: Blood
Blood (2014) 124 (21): 3436.
https://doi.org/10.1182/blood.V124.21.3436.3436
Published: 2014
Journal Articles

Generation of a Predictive Score for Ixazomib Response in Multiple Myeloma

Amit Kumar Mitra, PhD, Sanjoy Dey, Andrew Hangsleben, Michael Steinbach, Vipin Kumar, PhD, Brian Van Ness, PhD
Journal: Blood
Blood (2014) 124 (21): 5695.
https://doi.org/10.1182/blood.V124.21.5695.5695
Published: 2014